You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Litigation Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Docket	⤷ Try a Trial	Date Filed	2019-03-01
Court	District Court, D. Delaware	Date Terminated	2021-08-30
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To	Christopher J. Burke
Parties	ALVOGEN PINE BROOK LLC; JANSSEN BIOTECH, INC.; NATCO PHARMA LTD.; PHARMACYCLICS LLC
Patents	10,004,746; 10,010,507; 10,016,435; 10,106,548; 10,106,591; 10,125,140; 10,213,386; 10,213,415; 10,294,231; 10,294,232; 10,434,140; 10,548,850; 6,346,532; 7,342,117; 7,514,444; 7,879,828; 7,982,049; 8,008,309; 8,476,284; 8,497,277; 8,563,563; 8,697,711; 8,703,780; 8,735,403; 8,754,090; 8,754,091; 8,952,015; 8,957,079; 8,999,999; 9,018,192; 9,125,889; 9,181,257; 9,192,591; 9,192,662; 9,296,753; 9,302,002; 9,386,990; 9,415,004; 9,415,009; 9,540,382; 9,655,850; 9,655,857; 9,662,415; 9,713,617; 9,725,455; 9,752,191; 9,795,604; 9,801,881; 9,801,883; 9,814,721
Attorneys	Chanson Chang; Christopher D. Lynch; Cristina L. Martinez; David M. Hanna; David S. Denuyl; Hannah Lee; Irena Royzman; Jack B. Blumenfeld; James L. Higgins; Jeffrey J. Lyons; Jeremy A. Tigan; Marcus A. Colucci; Melanie K. Sharp; Michelle M. Ovanesian; Steven W. Lee
Firms	Baker & Hostetler; Morris, Nichols, Arsht & Tunnell; Proskauer Rose LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Biologic Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook LLC

The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2019-03-01	1	Complaint	PageID #: 2 Patent”); 9,655,857 (“the ’857 Patent”); 9,725,455 (“the ’455 Patent”); 10,010,507 (“the ’507… United States Patent Nos. 7,514,444 (“the ’444 Patent”); 8,008,309 (“the ’309 Patent”); 8,476,284 (“…(“the ’284 Patent”); 8,497,277 (“the ’277 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403…’403 Patent”); 8,754,090 (“the ’090 Patent”); 8,754,091 (“the ’091 Patent”); 8,952,015 (“the ’015 Patent…507 Patent”); 10,106,548 (“the ’548 Patent”); and 10,125,140 (“the ’140 Patent”).	External link to document
2019-06-10	14	Amended Complaint	: 1565 Patent”); 9,655,857 (“the ’857 Patent”); 9,725,455 (“the ’455 Patent”); 10,010,507 (“the ’507… United States Patent Nos. 7,514,444 (“the ’444 Patent”); 8,008,309 (“the ’309 Patent”); 8,476,284 (“…(“the ’284 Patent”); 8,497,277 (“the ’277 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403…’403 Patent”); 8,754,090 (“the ’090 Patent”); 8,754,091 (“the ’091 Patent”); 8,952,015 (“the ’015 Patent…507 Patent”); 10,106,548 (“the ’548 Patent”); 10,125,140 (“the ’140 Patent”); and 10,213,386 (“the ’	External link to document
2019-06-10	15	Patent/Trademark Report to Commissioner	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,213,386 . (Blumenfeld, Jack…2019 30 August 2021 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-03-12	180	Notice of Service	Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (7) Opening …. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos.9,655,857, (10) Opening Expert Report of Robert…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 and (11) Opening…Bodmeier Regarding Alvogen's Infringement of U.S. Patent No. 9,655,857 filed by Janssen Biotech, Inc., Pharmacyclics	External link to document
2020-03-12	181	Notice of Service	Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (7) Opening …. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos.9,655,857, (10) Opening Expert Report of Robert…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 and (11) Opening…Bodmeier Regarding Sandoz's Infringement of U.S. Patent No. 10,294,231 filed by Janssen Biotech, Inc.,	External link to document
2020-03-12	182	Notice of Service	Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (7) Opening …. Rule, B.M.B.S. Regarding Infringement of U.S. Patent No. 8,754,090 and Objective Indicia of Non-Obviousness…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,867 and (10) Opening Expert Report of…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 filed by Janssen… 1 March 2019 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-03-12	183	Notice of Service	Non-Obviousness Relating to, U.S. Patent Nos. 9,725,455, 9,296,753, 10,106,548 and 10,125,140, (6) Opening …Ronald Bodmeier Regarding Sun's Infringement of U.S. Patent No. 10,294,232 (2) Opening Expert Report of Dr.…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 9,655,867 and (7) Opening Expert Report of…Regarding Objective Indicia of Nonobviousness of U.S. Patent Nos. 10,294,231 and 10,294,232 filed by Janssen… 1 March 2019 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.